Clinical Trials Browser

Phase 2 × Ashwagandha × Clear all

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction